Background: The appearance of inhibitory antibodies against antihemophilic factors is one of the most serious complications related to hemophilia.
Objective: The objective of this study was to identify variables and factors related to the develop
Factors Involved in the Development of Inhibitory Antibodies in Patients with Hemophilia in Colombia: A Case-Control Study
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: Jorge E Machado-Alba, Laura A Chica-Quintero, Manuel E Machado-Duque, Andrés Gaviria-Mendoza, Juan David Wilches-Gutierrez, Diana Rocio Arias-Osorio
- Idiomas: Inglés
- Palabras clave: Hemofilia A, hemofilia B, inhibidores del factor de coagulación sanguínea, factores de riesgo, farmacoepidemiologíaHemophilia A, hemophilia B, blood coagulation factor inhibitors, risk factors, pharmacoepidemiology
Machado-Alba JE, Chica-Quintero LA, Machado-Duque ME, Gaviria-Mendoza A, Wilches-Gutierrez JD, Arias-Osorio DR. Factors Involved in the Development of Inhibitory Antibodies in Patients with Hemophilia in Colombia: A Case-Control Study. Clin Med Insights B Enlace: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543110/
